Literature DB >> 3917781

Circulating catecholamines in acute asthma.

P W Ind, R C Causon, M J Brown, P J Barnes.   

Abstract

Plasma catecholamine concentrations were measured in 15 patients (six male) aged 14-63 years attending the casualty department with acute severe asthma (peak expiratory flow 27% (SEM 3%) of predicted). Nine patients were admitted and six were not. The plasma noradrenaline concentration, reflecting sympathetic nervous discharge, was two to three times normal in all patients and was significantly higher in those who required admission compared with those discharged home (mean 7.7 (SEM 0.6) v 4.7 (0.5) nmol/l (1.3 (SEM 0.1) v 0.8 (0.08) ng/ml); p less than 0.001). Plasma adrenaline concentration, however, was not increased in any patient. This surprising failure of the plasma adrenaline concentration to increase during the stress of an acute attack of asthma was unexplained and contrasts with the pronounced rise in plasma adrenaline and noradrenaline concentrations in acute myocardial infarction, heart failure, and septicaemia. The failure of plasma adrenaline concentration to increase in acute asthma is unlikely to be explained by adrenal exhaustion, but it may be another example of impaired adrenaline secretion in asthma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917781      PMCID: PMC1417554          DOI: 10.1136/bmj.290.6464.267

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  Nasal mucociliary clearance in man.

Authors:  D F Proctor; G K Adams; I Andersen; S F Man
Journal:  Ciba Found Symp       Date:  1978

2.  The arterial-alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations.

Authors:  R Gilbert; J F Keighley
Journal:  Am Rev Respir Dis       Date:  1974-01

3.  Decreased plasma free fatty acids and urinary epinephrine in bronchial asthma.

Authors:  A A Mathé; P H Knapp
Journal:  N Engl J Med       Date:  1969-07-31       Impact factor: 91.245

Review 4.  Autonomic regulation of the airways.

Authors:  J A Nadel; P J Barnes
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

5.  Endogenous plasma adrenaline in asthma.

Authors:  P J Barnes
Journal:  Eur J Respir Dis       Date:  1983-11

6.  Sympathoadrenal reactivity in exercise-induced asthma.

Authors:  K Larsson; P Hjemdahl; A Martinsson
Journal:  Chest       Date:  1982-11       Impact factor: 9.410

7.  Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality.

Authors:  R P Karlsberg; P E Cryer; R Roberts
Journal:  Am Heart J       Date:  1981-07       Impact factor: 4.749

8.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.

Authors:  G S Francis; S R Goldsmith; S M Ziesche; J N Cohn
Journal:  Am J Cardiol       Date:  1982-04-01       Impact factor: 2.778

9.  Plasma histamine and catecholamines in stable asthmatic subjects.

Authors:  P J Barnes; P W Ind; M J Brown
Journal:  Clin Sci (Lond)       Date:  1982-06       Impact factor: 6.124

10.  Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage.

Authors:  C R Benedict; D G Grahame-Smith
Journal:  Q J Med       Date:  1978-01
View more
  19 in total

1.  Plasma catecholamine responses in acute severe asthma.

Authors:  T R Parke; D J Steedman; C E Robertson; R A Little; P F Maycock
Journal:  Arch Emerg Med       Date:  1992-06

2.  Humoral control of airway tone.

Authors:  N C Thomson; K D Dagg; S G Ramsay
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

3.  Adrenaline, bronchoconstriction, and asthma.

Authors:  A Morice; P Sever; P Ind
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

4.  Defensiveness and individual response stereotypy in asthma.

Authors:  Jonathan M Feldman; Paul M Lehrer; Stuart M Hochron; Gary E Schwartz
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

5.  Is current treatment increasing asthma mortality and morbidity?

Authors:  I Gregg
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

6.  The mechanism of salbutamol-induced hypokalaemia.

Authors:  K F Whyte; G J Addis; R Whitesmith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

7.  Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi.

Authors:  R W Hauck; C Schulz; H P Emslander; M Böhm
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

8.  Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function.

Authors:  E A Millar; R M Angus; G Hulks; J J Morton; J M Connell; N C Thomson
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

9.  Circulating adrenaline and noradrenaline concentrations during exercise in patients with exercise induced asthma and normal subjects.

Authors:  K E Berkin; G Walker; G C Inglis; S G Ball; N C Thomson
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

10.  Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline.

Authors:  K F Whyte; C Reid; G J Addis; R Whitesmith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.